+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point of Care Testing Market by Product (Blood Glucose Monitoring, Cardiac Marker Testing, Coagulation Testing), Technology (Biosensor Technology, Lateral Flow Immunoassay, Microfluidics), Sample Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Point of Care Testing Market by Product (Blood Glucose Monitoring, Cardiac Marker Testing, Coagulation Testing), Technology (Biosensor Technology, Lateral Flow Immunoassay, Microfluidics), Sample Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Point of Care Testing Market by Product (Blood Glucose Monitoring, Cardiac Marker Testing, Coagulation Testing), Technology (Biosensor Technology, Lateral Flow Immunoassay, Microfluidics), Sample Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968870
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Point of Care Testing Market grew from USD 32.56 billion in 2024 to USD 36.80 billion in 2025. It is expected to continue growing at a CAGR of 12.79%, reaching USD 67.07 billion by 2030.

Contextual Overview of How Point of Care Testing Is Redefining Healthcare Delivery with Unprecedented Accessibility and Precision

Point of care testing has swiftly moved from the periphery of clinical diagnostics to a pivotal role in healthcare delivery. Fueled by advances in miniaturization, real-time data analytics, and user-friendly interfaces, these rapid diagnostic solutions are reshaping patient experiences across ambulatory centers, home care settings, and acute care environments. The decentralization of laboratory services has reduced turnaround times for critical results, empowering clinicians with immediate insights that drive timely therapeutic interventions and improve patient outcomes.

In response to this transformative shift, healthcare providers are re-evaluating traditional diagnostic workflows and embracing integrated testing platforms that seamlessly connect to electronic health record systems. As regulatory frameworks adapt to balance innovation with patient safety, stakeholders including manufacturers, care providers, and distributors are navigating new opportunities to enhance access to diagnostics. This executive summary introduces the foundational concepts, outlines the catalysts of change, and establishes the context for understanding how point of care testing is influencing clinical pathways and operational efficiencies.

Revolutionary Shifts in the Point of Care Testing Landscape Triggered by Technological Convergence and Evolving Patient Centric Models

Technological convergence is driving unprecedented shifts in the point of care testing arena. Miniaturized biosensors, advanced microfluidic cartridges, and next-generation lateral flow immunoassays are enabling precise, multiplexed analyses at the patient bedside. These innovations, coupled with seamless digital connectivity, are catalyzing a move toward predictive and preventive care models where diagnostic insights inform real-time decision making.

Furthermore, the evolution of patient-centric approaches is reshaping care pathways. Remote monitoring programs integrate point of care devices with telehealth platforms, empowering patients to participate actively in managing chronic conditions. Concurrently, regulatory authorities are establishing clearer guidelines to ensure device reliability without stifling innovation. As a result, established diagnostic laboratories are partnering with point of care providers to co-develop solutions that maintain analytical rigor while accelerating result delivery, underscoring a collaborative ecosystem that prioritizes both accuracy and accessibility.

Assessing the Cumulative Impact of Newly Imposed Tariff Regulations in the United States during 2025 on Point of Care Testing Supply Chains

The imposition of new tariffs on diagnostic reagents and device components in 2025 has introduced complexities into the supply chain for point of care testing. Manufacturers reliant on imported microfluidic cartridges and biosensor elements have encountered increased input costs, prompting a reassessment of supplier portfolios. In response, many producers are engaging in strategic dialogues with alternative vendors to diversify sourcing and mitigate risk.

At the same time, the heightened cost environment has incentivized collaborative negotiations between device manufacturers and reagent suppliers to explore localized production capabilities. Some organizations are investigating co-investment models to establish domestic manufacturing hubs, thereby reducing exposure to international trade fluctuations. Importantly, government incentives aimed at bolstering onshore production of critical healthcare components are beginning to align with these strategic initiatives, setting the stage for more resilient, regionally anchored supply networks.

Unveiling Key Segmentation Insights That Illuminate Market Dynamics Across Product Technology Sample Type End User and Distribution Channels

Based on product classification, blood glucose monitoring remains a cornerstone application owing to the prevalence of diabetes, while cardiac marker testing is gaining traction in emergency and ambulatory settings for rapid risk assessment. Coagulation and hematology testing applications are expanding into decentralized clinics, and the demand for drug abuse, infectious disease, pregnancy and fertility, and urinalysis testing underscores the breadth of clinical use cases addressed by point of care platforms.

Regarding technology, biosensor platforms leverage electrochemical and optical detection modalities to deliver quantitative analyses, whereas lateral flow immunoassays offer simplicity and cost efficiency for qualitative or semi-quantitative screening. Microfluidics has emerged as an enabling technology for integrating multiple assay steps into compact cartridges, supporting multiplexed testing with minimal user intervention.

When considering sample types, blood remains the predominant matrix for diagnostic accuracy, and saliva testing is rapidly advancing in noninvasive applications such as hormone assays. Urine testing continues to serve as a versatile medium for drug abuse and metabolic screenings. From the end user perspective, ambulatory care centers and clinics appreciate the convenience of on-site testing, diagnostic laboratories value confirmatory workflows, home care models rely on patient-friendly designs, and hospitals integrate these tools into critical care protocols. Distribution channels encompass direct sales relationships that foster bespoke service agreements, distributor networks that extend market reach, and ecommerce platforms that provide rapid procurement options.

Delineating Regional Nuances and Growth Drivers Spanning the Americas Europe Middle East Africa and Asia Pacific Markets

In the Americas, established reimbursement pathways and advanced healthcare infrastructures continue to support the adoption of integrated point of care solutions. North American stakeholders are investing heavily in digital health initiatives, with interoperability and data security emerging as critical focal points to ensure seamless clinical integration and regulatory compliance.

Across Europe, Middle East, and Africa, diverse regulatory environments and varying economic conditions shape implementation strategies. In Western Europe, harmonized regulations and mature markets drive the adoption of sophisticated platforms, while emerging economies in the Middle East and Africa focus on building basic diagnostic capabilities to address infectious disease burdens and maternal health challenges.

The Asia-Pacific region presents a dynamic ecosystem characterized by rapid urbanization and expanding healthcare access. Governments are prioritizing investments in domestic manufacturing and rural healthcare delivery, fostering partnerships that accelerate the deployment of mobile testing units and digital connectivity. This strategic emphasis on local innovation underscores the region’s potential to influence global supply chains and drive new use cases in point of care diagnostics.

Identifying Leading Stakeholders Driving Innovation Strategic Collaborations and Competitive Positioning within the Point of Care Testing Ecosystem

Leading multinational corporations continue to shape the strategic direction of point of care testing through sustained investments in research and development, bolstered by targeted acquisitions that enhance platform capabilities. These industry giants often collaborate with academic research centers to validate novel biomarkers and refine analytical performance, ensuring their offerings meet stringent clinical requirements.

Simultaneously, agile mid-sized innovators are disrupting established paradigms with specialized solutions designed for niche applications, such as at-home fertility panels or portable immunoassays for infectious diseases. Through strategic alliances and joint ventures, these nimble players gain access to global distribution networks, while larger partners benefit from cutting-edge technology pipelines.

Partnerships between device manufacturers and digital health startups are also accelerating the integration of point of care data into telemedicine platforms. This convergence is fostering new service models in which software-driven decision support augments traditional diagnostics, reinforcing competitive differentiation and unlocking value across the continuum of care.

Actionable Strategic Recommendations Empowering Industry Leaders to Capitalize on Emerging Opportunities in the Evolving Point of Care Testing Space

Industry leaders should prioritize the integration of digital platforms that connect point of care devices to centralized health information systems, thereby ensuring secure, real-time data flow and enhancing the clinician decision support ecosystem. Collaboration with healthcare providers to pilot test new workflows will help refine user interfaces, optimize training programs, and drive adoption among clinical staff.

Further, diversifying supply chains by forging partnerships with regional manufacturers can mitigate the impact of trade policy fluctuations and reduce lead times for critical components. Engaging in co-development agreements with reagent suppliers will facilitate the creation of customized assays, fostering greater product differentiation.

Moreover, stakeholders are advised to explore subscription-based service models that transition capital expenditure into predictable operating costs. This shift can improve budget planning for healthcare systems and expand access to advanced testing platforms. Finally, active engagement with regulatory bodies to shape policy frameworks will enable faster market entry and provide a competitive edge in emerging regions where point of care diagnostics can address unmet clinical needs.

Comprehensive Research Methodology Detailing Data Collection Analytical Frameworks and Validation Processes Underpinning the Study

The research methodology underpinning this analysis combined comprehensive secondary research with targeted primary interviews of industry executives, clinical end users, and regulatory experts. Secondary sources included peer-reviewed journals, patent filings, regulatory agency publications, and reputable industry white papers. Insights from global trade databases and public financial disclosures informed the understanding of supply chain dynamics and tariff impacts.

Primary research involved in-depth discussions with senior decision makers across device manufacturers, distribution partners, and healthcare institutions to validate trends and assess the practical implications of technological advancements. Qualitative insights were corroborated through expert panels that evaluated analytical performance criteria and usability requirements. Data triangulation ensured the reliability of conclusions, while confidentiality agreements preserved the integrity of proprietary information.

Synthesis of Critical Findings and Strategic Implications Underscoring the Transformative Impact of Point of Care Testing Innovations

This report synthesizes critical findings that underscore the transformative potential of rapid diagnostics at the patient point of care. The convergence of advanced biosensor technologies and digital health ecosystems is accelerating the integration of diagnostics into routine care, reducing reliance on centralized laboratories and enhancing clinical decision timelines.

Strategic collaborations between multinational manufacturers, innovative startups, and healthcare providers are fostering a dynamic ecosystem in which regulatory harmonization and supply chain resilience are paramount. Regional disparities in infrastructure and reimbursement models present both challenges and opportunities that require nuanced approaches tailored to specific market contexts.

Ultimately, organizations that embrace agile operating models, invest in interoperable digital platforms, and cultivate diversified partnerships will be best positioned to capitalize on emerging use cases and deliver patient-centric diagnostic solutions. The insights presented in this summary provide a foundation for informed strategy development as the point of care testing landscape continues to evolve.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Blood Glucose Monitoring
    • Cardiac Marker Testing
    • Coagulation Testing
    • Drug Abuse Testing
    • Hematology Testing
    • Infectious Disease Testing
    • Pregnancy & Fertility Testing
    • Urinalysis Testing
  • Technology
    • Biosensor Technology
    • Lateral Flow Immunoassay
    • Microfluidics
  • Sample Type
    • Blood
    • Saliva
    • Urine
  • End User
    • Ambulatory Care Centers
    • Clinics
    • Diagnostic Laboratories
    • Home Care
    • Hospitals
  • Distribution Channel
    • Direct Sales
    • Distributor Sales
    • Ecommerce
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Quidel Corporation
  • Hologic, Inc.
  • OraSure Technologies, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms to improve point of care test result interpretation and predictive analytics
5.2. Expansion of molecular lab on a chip platforms for rapid multiplex pathogen detection in decentralized settings
5.3. Adoption of smartphone enabled biosensors and connected devices for seamless remote patient monitoring and diagnostics
5.4. Development of CRISPR based point of care assays for highly specific and rapid detection of infectious diseases
5.5. Strategic partnerships between device manufacturers and telemedicine providers to streamline virtual diagnostics and care delivery
5.6. Regulatory harmonization and reimbursement pathway evolution to support widespread adoption of novel point of care technologies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Point of Care Testing Market, by Product
8.1. Introduction
8.2. Blood Glucose Monitoring
8.3. Cardiac Marker Testing
8.4. Coagulation Testing
8.5. Drug Abuse Testing
8.6. Hematology Testing
8.7. Infectious Disease Testing
8.8. Pregnancy & Fertility Testing
8.9. Urinalysis Testing
9. Point of Care Testing Market, by Technology
9.1. Introduction
9.2. Biosensor Technology
9.3. Lateral Flow Immunoassay
9.4. Microfluidics
10. Point of Care Testing Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Saliva
10.4. Urine
11. Point of Care Testing Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Home Care
11.6. Hospitals
12. Point of Care Testing Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributor Sales
12.4. Ecommerce
13. Americas Point of Care Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Point of Care Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Point of Care Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Danaher Corporation
16.3.4. Siemens Healthineers AG
16.3.5. Becton, Dickinson and Company
16.3.6. Thermo Fisher Scientific Inc.
16.3.7. bioMérieux SA
16.3.8. Quidel Corporation
16.3.9. Hologic, Inc.
16.3.10. OraSure Technologies, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. POINT OF CARE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. POINT OF CARE TESTING MARKET: RESEARCHAI
FIGURE 26. POINT OF CARE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. POINT OF CARE TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. POINT OF CARE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKER TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DRUG ABUSE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DRUG ABUSE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINALYSIS TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINALYSIS TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BIOSENSOR TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BIOSENSOR TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. CANADA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. CANADA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. CANADA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. CANADA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. CANADA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. MEXICO POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. MEXICO POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. MEXICO POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. MEXICO POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. GERMANY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 150. GERMANY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 151. GERMANY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. GERMANY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. GERMANY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. GERMANY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. GERMANY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. FRANCE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. FRANCE POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. FRANCE POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. FRANCE POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. FRANCE POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. FRANCE POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. FRANCE POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. FRANCE POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. FRANCE POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. FRANCE POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. ITALY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 180. ITALY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 181. ITALY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. ITALY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. ITALY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. ITALY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. ITALY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ITALY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ITALY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. ITALY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. SPAIN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. SPAIN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. SPAIN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. SPAIN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. SPAIN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. SPAIN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. SPAIN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. SPAIN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. SPAIN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. SPAIN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 210. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. DENMARK POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 230. DENMARK POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 231. DENMARK POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. DENMARK POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. DENMARK POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 234. DENMARK POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 235. DENMARK POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. DENMARK POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. DENMARK POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. DENMARK POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 244. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 245. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. QATAR POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. QATAR POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. QATAR POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. QATAR POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. QATAR POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 254. QATAR POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 255. QATAR POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. QATAR POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. QATAR POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. QATAR POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. FINLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. FINLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. FINLAND POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. FINLAND POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. FINLAND POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 264. FINLAND POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 265. FINLAND POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. FINLAND POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. FINLAND POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. FINLAND POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 270. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 271. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 274. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 275. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SWEDEN POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 280. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 281. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. NIGERIA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. EGYPT POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. EGYPT POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. EGYPT POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. EGYPT POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. EGYPT POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. EGYPT POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. EGYPT POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. EGYPT POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. EGYPT POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. EGYPT POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. TURKEY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 300. TURKEY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 301. TURKEY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. TURKEY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. TURKEY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 304. TURKEY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 305. TURKEY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. TURKEY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. TURKEY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. TURKEY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 314. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 315. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. ISRAEL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NORWAY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 320. NORWAY POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 321. NORWAY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. NORWAY POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. NORWAY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 324. NORWAY POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 325. NORWAY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. NORWAY POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. NORWAY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. NORWAY POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. POLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 330. POLAND POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 331. POLAND POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 332. POLAND POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 333. POLAND POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 334. POLAND POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 335. POLAND POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. POLAND POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. POLAND POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. POLAND POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. SWITZERLAND

Samples

Loading
LOADING...

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Quidel Corporation
  • Hologic, Inc.
  • OraSure Technologies, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 36.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.07 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Cardiac Point of Care Testing Market by Product Type, End User, Distribution Channel, Test Mode, Technology, Application - Global Forecast to 2030 - Product Image

Cardiac Point of Care Testing Market by Product Type, End User, Distribution Channel, Test Mode, Technology, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type (Lateral Flow Immunoassay, Paper-based Rapid Diagnostics), Technology, Age Group, Distribution Channel, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Rapid Point-of-Care Testing for Sickle Cell Anemia Market Size, Share & Trends Analysis Report by Type (Lateral Flow Immunoassay, Paper-based Rapid Diagnostics), Technology, Age Group, Distribution Channel, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
Point of Care Testing Market by Product Type, Sample Type and Technology - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Point of Care Testing Market by Product Type, Sample Type and Technology - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 205 Pages
  • Global
From
Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Point of Care Testing (POCT) Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From
POCT (Point of Care Testing) Cardiac Disease Market Opportunities and Strategies to 2033 - Product Image

POCT (Point of Care Testing) Cardiac Disease Market Opportunities and Strategies to 2033

  • Report
  • 284 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.